- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Bioventus Inc(BVS)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for BVS
11/20/2026: BVS (2-star) is currently NOT-A-BUY. Pass it for now.
Bioventus Inc is a medical technology company specializing in pain treatments, surgical solutions, and restorative therapies for musculoskeletal care. The company exhibits solid business strengths, highlighted by robust gross margins and strong demand for key products like DUROLANE joint injections. Its primary investment story centers on an ongoing operational turnaround and a strategic alternatives review exploring potential corporate sale opportunities. Key risks include heavy reliance on core product lines, debt obligations, and intense competition from larger orthopedic conglomerates. The stock suits value-oriented investors willing to monitor strategic transaction updates and regulatory reimbursement trends.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | Moderate organic growth rates appeal more to steady compounders than high-octane growth seekers. |
| Momentum investor | Strong fit while signal remains positive | Positive earnings updates and strategic review headlines frequently trigger sharp upward momentum bursts. |
| Value investor | Strong fit | Trading at reasonable earnings and sales multiples, the stock attracts value seekers focused on turnaround stories. |
| Dividend investor | Weak fit | The company does not pay dividends, directing cash flow toward debt service and business reinvestment. |
| Low-risk investor | Mixed fit | Small-cap medical device volatility and leverage risks limit its suitability for ultra-conservative portfolios. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Medium / high | As a small-cap healthcare stock, its share price can react sharply to earnings reports and corporate headlines. |
| Valuation risk | Medium | Reasonable earnings multiples provide some valuation buffer, but execution missteps could compress multiples. |
| Competition risk (Orthopedic giants) | High | Well-capitalized medical device competitors possess greater R&D and marketing scale. |
| Business quality | Medium | Solid gross margins and niche market positions highlight respectable franchise quality. |
| Dividend income | Low / none | Income-focused investors receive no cash return via dividends. |
| Execution risk | Medium / high | Sustaining margin improvements and navigating strategic reviews require flawless management execution. |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 676.53M USD | Price to earnings Ratio 12.2 | 1Y Target Price 16.6 |
Price to earnings Ratio 12.2 | 1Y Target Price 16.6 | ||
Volume (30-day avg) 607.3K shares | Beta 0.62 | 52 Weeks Range 7.01 - 15.89 | Updated Date 11/21/2026 |
52 Weeks Range 7.01 - 15.89 | Updated Date 11/21/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.81 |
Sector & Industry Intelligence
Sector
Healthcare
Constructive- Sentiment
- Strong Bullish
- Momentum
- BUY Breadth Improving
- BUY participation
- 55.2%
- Active BUY / eligible
- 53 / 96
- 30-Day BUY Count Change
- +19
- Market state
- Strong Bullish
More qualifying stocks are receiving or maintaining BUY advisories, indicating improving market participation.
Industry
Medical Devices
- BUY participation
- 33.3%
- Active BUY / eligible
- 2 / 6
- 30-Day BUY Count Change
- +2
Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.
Price Behavior

Rolling Over
The price momentum is slowing down and beginning to turn downward.

Choppy
The stock has experienced frequent reversals and pronounced short-term price swings.
Analysis of Past Performance
Type Stock | Historic Profit 31.22% | Avg. Invested days 40 | Today’s Advisory PASS |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals 
Financial Health Rating 
Growth Momentum Score 
Ownership 
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue) 
Economic Dimensions
Quantitative Style Profile 
Style Classification
Quality Focused
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Pain Treatments | Intra-articular hyaluronic acid injections such as DUROLANE and GELSYN-3 for knee osteoarthritis. | This is a primary profit engine driven by recurring patient treatments for joint pain. |
| Restorative Therapies | Non-invasive active healing devices like the EXOGEN ultrasound bone stimulation system. | Provides steady revenue from orthopedic recovery and fracture healing markets. |
| Surgical Solutions | Bone graft substitutes and surgical adjuncts used in spine, trauma, and orthopedic procedures. | Links company performance directly to hospital surgical procedural volumes. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2026-11-02 | When After Market | Estimate 0.17 | Actual 0.17 |
Profitability
Profit Margin 9.78% | Operating Margin (TTM) 10.08% |
Management Effectiveness
Return on Assets (TTM) 5.37% | Return on Equity (TTM) 25.78% |
Valuation
Trailing PE 12.2 | Forward PE 11.25 | Enterprise Value 880.44M | Price to Sales(TTM) 1.16 |
Enterprise Value 880.44M | Price to Sales(TTM) 1.16 | ||
Enterprise Value to Revenue 1.5 | Enterprise Value to EBITDA 8.66 | Shares Outstanding 68.47M | Shares Floating 34.06M |
Shares Outstanding 68.47M | Shares Floating 34.06M | ||
Percent Insiders 11.62 | Percent Institutions 86.95 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

